These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27427875)

  • 1. Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
    Pérez-Santiago J; Ouchi D; Urrea V; Carrillo J; Cabrera C; Villà-Freixa J; Puig J; Paredes R; Negredo E; Clotet B; Massanella M; Blanco J
    AIDS; 2016 Sep; 30(15):2275-87. PubMed ID: 27427875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
    Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
    AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4
    Gómez-Mora E; García E; Urrea V; Massanella M; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    Sci Rep; 2017 Sep; 7(1):11711. PubMed ID: 28916780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
    Massanella M; Gómez-Mora E; Carrillo J; Curriu M; Ouchi D; Puig J; Negredo E; Cabrera C; Clotet B; Blanco J
    J Transl Med; 2015 Jul; 13():230. PubMed ID: 26183947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Álvarez-Ríos AI; Genebat M; Abad-Carrillo MA; Ruiz-Mateos E; Pulido F; González-García J; Montero M; Bernal-Morell E; Vidal F; Leal M; Pacheco YM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
    Negredo E; Massanella M; Puertas MC; Buzón MJ; Puig J; Pérez-Alvárez N; Pérez-Santiago J; Bonjoch A; Moltó J; Jou A; Echeverría P; Llibre JM; Martínez-Picado J; Clotet B; Blanco J
    J Antimicrob Chemother; 2013 Oct; 68(10):2358-62. PubMed ID: 23677919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.
    Collazos J; Valle-Garay E; Carton JA; Montes AH; Suarez-Zarracina T; De la Fuente B; Asensi V
    HIV Med; 2016 Aug; 17(7):532-41. PubMed ID: 26754349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4
    Tanaskovic S; Price P; French MA; Fernandez S
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):101-109. PubMed ID: 27701900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.
    Tanaskovic S; Fernandez S; Price P; French MA
    AIDS; 2014 Mar; 28(6):821-30. PubMed ID: 24499954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
    AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
    AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological recovery and antiretroviral therapy in HIV-1 infection.
    Battegay M; Nüesch R; Hirschel B; Kaufmann GR
    Lancet Infect Dis; 2006 May; 6(5):280-7. PubMed ID: 16631548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
    Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults.
    Yotebieng M; Maskew M; Van Rie A
    AIDS; 2015 Jun; 29(9):1067-75. PubMed ID: 26125140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients.
    Lichtner M; Rossi R; Vita S; Savinelli S; Iannetta M; Mascia C; Marocco R; Ajassa C; Mengoni F; Scorzolini L; Maria Mastroianni C; Vullo V
    Curr HIV Res; 2016; 14(4):331-9. PubMed ID: 26785889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.